Hypertension drug effective at preventing atherosclerosis

April 03, 2000

WINSTON-SALEM, N.C. -- Blocking the hormone that causes high blood pressure can reduce the development of heart vessel disease, report researchers from Wake Forest University Baptist Medical Center in this week's issue of Circulation. The research team found that the hypertension drug Losartan reduced by half the buildup of fatty deposits in the heart vessels of monkeys fed a high-fat diet. The drug works by blocking angiotensin II, a hormone that causes high blood pressure and in recent years has been suspected as a cause of blood vessel disease.

"Evidence is mounting that there is a basic hormonal mechanism that causes the various facets of cardiovascular disease," said Carlos Ferrario, M.D., director of the Hypertension and Vascular Disease Center.

"The results imply that in order to prevent plaque buildup in vessels, we may need to treat not only cholesterol, but to treat the hormone linked to hypertension," said Ferrario. "Cholesterol-lowering drugs prevent heart attacks in only about 30 percent of people who take them. Perhaps we could improve those statistics by also treating angiotensin II."

The study used cynomolgus monkeys that didn't have high blood pressure. The monkeys, which have marked similarities to humans in the development of cardiovascular disease, were fed a high-fat diet that raised their cholesterol levels to about 300. From previous studies, the researchers knew that fatty streaks, the first sign of vessel disease, begin to form after 18 weeks on the diet. At 12 weeks, half of the monkeys received Losartan for six weeks. After 20 weeks on the diet, the researchers found that fatty streak development was reduced by 50 percent in the monkeys that received Losartan. There were no changes in cholesterol or blood pressure levels that could have accounted for the difference.

"What we have is further evidence that angiotensin II is involved in the initiation of atherosclerosis," said William Strawn, D.V.M, Ph.D., the article's lead author. "It appears that the hormone is actually a risk factor for developing blood vessel disease."

Researchers believe Losartan's effect was caused by the drug's ability to protect low-density lipoproteins, the so-called "bad" cholesterol, from oxidization. Oxidation increases the toxic effect of cholesterol on arteries. "These drugs are obviously more than hypertensive agents," said Ferrario. "The results suggest that treating hypertensive patients with drugs to block the actions of angiotensin II will slow down or prevent the development of atherosclerosis."

Ferrario said it is too early to recommend that non-hypertensive patients be treated with Losartan. He predicted, however, that future treatments for patients with high cholesterol and other risk factors for heart attack might include both lipid-lowering and anti-hypertensive drugs. He called for additional research to duplicate the findings in humans and to understand the mechanisms that cause hypertension and atherosclerosis.

Other members of the research team were Mark C. Chappell, Ph.D., and Richard H. Dean, M.D., from the Medical Center and Salah Kivlighn, Ph.D., from Merck & Co., which manufactures Losartan and funded the research.
-end-
Media Contacts: Karen Richardson, (336) 716-4453 or Jim Steele, (336) 716-3487.

Wake Forest Baptist Medical Center

Related Cardiovascular Disease Articles from Brightsurf:

Changes by income level in cardiovascular disease in US
Researchers examined changes in how common cardiovascular disease was in the highest-income earners compared with the rest of the population in the United States between 1999 and 2016.

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne.

A talk with your GP may prevent cardiovascular disease
Having a general practitioner (GP) who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

Dilemma of COVID-19, aging and cardiovascular disease
Whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19) is discussed in this article.

Air pollution linked to dementia and cardiovascular disease
People continuously exposed to air pollution are at increased risk of dementia, especially if they also suffer from cardiovascular diseases, according to a study at Karolinska Institutet in Sweden published in the journal JAMA Neurology.

New insights into the effect of aging on cardiovascular disease
Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts.

Premature death from cardiovascular disease
National data were used to examine changes from 2000 to 2015 in premature death (ages 25 to 64) from cardiovascular disease in the United States.

Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Despite the ACA, millions of Americans with cardiovascular disease still can't get care
Cardiovascular disease (CVD) is the leading cause of death for Americans, yet millions with CVD or cardiovascular risk factors (CVRF) still can't access the care they need, even years after the implementation of the Affordable Care Act (ACA).

Excess weight and body fat cause cardiovascular disease
In the first Mendelian randomization study to look at this, researchers have found evidence that excess weight and body fat cause a range of heart and blood vessel diseases (rather than just being associated with it).

Read More: Cardiovascular Disease News and Cardiovascular Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.